Largest biotech by total liabilities

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Amgen leads the 24 biotech ranked by total liabilities, at R$474.9B, ahead of Gilead Sciences (R$211B) and Biogen (R$64.8B). Figures as of 18 Nov 2026, 13:42 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenR$474.9B
Median
R$4.1B
Combined market value
R$4.92T
Countries
5

Market values as of .

Largest biotech by total liabilities
#CompanyTotal liabilities ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareR$474.9BR$1.44TR$2,654.48 0.95% down 34% up United States
2Gilead SciencesGILD · Health CareR$211BR$1.22TR$986.95 1.60% up 33% up United States
3BiogenBIIB · Health CareR$64.8BR$214.9BR$1,453.75 0.34% down 49% up United States
4ModernaMRNA · Health CareR$21.4BR$485BR$1,198.76 3.93% down 755% up United States
5BioNTechBNTX · Health CareR$17.8BR$122BR$491.91 0.47% down 16% down Germany
6QiagenQGEN · Health CareR$14.5BR$59.6BR$288.39 0.12% down 12% up Netherlands
7Halozyme TherapeuticsHALO · Health CareR$14.4BR$63.4BR$556.31 0.55% down 37% up United States
8Neurocrine BiosciencesNBIX · Health CareR$8BR$97.4BR$961.79 0.37% up 20% up United States
9argenxARGX · Health CareR$7.9BR$345.4BR$5,492.49 0.36% down 4% up Belgium
10ImmunityBioIBRX · Health CareR$5.8BR$38.6BR$36.29 4.68% up 193% up United States
11RepligenRGEN · Health CareR$4.9BR$60.1BR$940.11 0.37% down 5% up United States
12Revolution MedicinesRVMD · Health CareR$4.2BR$204BR$943.07 2.50% down 131% up United States
13ExelixisEXEL · Health CareR$4BR$96.9BR$397.07 2.09% up 63% up United States
14Bio-TechneTECH · Health CareR$2.8BR$66.1BR$421.01 0.22% down 26% up United States
15CRISPR TherapeuticsCRSP · Health CareR$2BR$22.6BR$232.74 0.54% down 21% down Switzerland
16VaxcytePCVX · Health CareR$1.8BR$54.5BR$344.32 3.59% down 22% up United States
17Adaptive BiotechnologiesADPT · Health CareR$1.7BR$26.7BR$165.15 2.22% up 88% up United States
18Kodiak SciencesKOD · Health CareR$1.1BR$36.7BR$561.12 3.90% down 396% up United States
19Twist BioscienceTWST · Health CareR$979.1MR$44.3BR$649.23 6.63% up 340% up United States
20Kymera TherapeuticsKYMR · Health CareR$945.7MR$60.1BR$704.41 3.44% down 87% up United States
21Scholar Rock HoldingSRRK · Health CareR$920.4MR$31.9BR$261.32 1.21% up 14% up United States
22Krystal BiotechKRYS · Health CareR$662.2MR$51.3BR$1,730.60 0.22% up 46% up United States
23ImmunovantIMVT · Health CareR$605.3MR$39.8BR$192.51 0.21% down 43% up United States
24CG OncologyCGON · Health CareR$226MR$40.9BR$457.59 6.89% down 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 5.7967 BRL).

Questions and answers

Which biotech rank first by total liabilities?

Amgen (R$474.9B), Gilead Sciences (R$211B) and Biogen (R$64.8B) are the top three of the 24 biotech ranked by total liabilities as of 18 Nov 2026, 13:42 UTC.

How many biotech are in this ranking?

24 are ranked by total liabilities.

What are these biotech worth together?

The 24 biotech ranked by total liabilities have a combined market value of R$4.92T as of 18 Nov 2026, 13:42 UTC.

What does ranking by total liabilities measure?

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Cite this page

Funkfolio, “Largest biotech by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-liabilities

Underlying data: Yahoo Finance; SEC EDGAR.